Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Help Helene victims: Click to give money, give blood, donate goods or volunteer â¤ï¸ Here's your guide to help our western NC neighbors
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Mainz BioMed NV
< Previous
1
2
Next >
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
November 13, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
November 09, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
November 07, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
October 31, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
October 26, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
October 18, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
October 11, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit
October 05, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
October 04, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
September 27, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 81%
September 13, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market
September 05, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference
August 29, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland
August 22, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update
August 15, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
ASX:MAP
MYNZ
Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom
August 01, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Collaboration with Fugene Genetics in Israel
July 18, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Secures up to $50M in New Funding
June 29, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain
June 28, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Expands into Romania Through Partnership with Bioclinica
June 20, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Expands Commercial Footprint into Poland
May 31, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöeller-Kipper
May 24, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update
May 16, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert
May 10, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
ASX:MAP
MYNZ
Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network of Lab Partners
May 03, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Participate in Digestive Disease Week 2023
May 01, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany
April 27, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal
April 26, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
Mainz Biomed Provides Full Year 2022 Financial Results
April 10, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Tickers
MYNZ
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.